A Study Designed to Evaluate the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 in Healthy Volunteers
Clinical trial NCT03762031 · COMPLETED
Trial details
- NCT number
- NCT03762031
- Sponsor
- Galera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-19
- Primary completion
- 2020-03-04
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.